| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Pharmaceuticals
| Recent successes in clinical trials, particularly for Fabhalta, highlight the promising advancements in Novartis AG's product development efforts. The innovative drug development strategies showcased by positive phase 2b results for Akero's EFX further indicate a proactive approach to addressing unmet medical needs. These developments suggest a strong potential for both market expansion and enhanced treatment options in niche therapeutic areas. However, the challenges of regulatory approvals and market competition remain critical considerations. |
| The price action of Novartis AG (NVS) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 0.2 is modestly bullish. The market sentiment at -0.1 is modestly bearish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. There is no clear direction for NVS since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.9, and the negative at -1 on 2025-10-16. The forces of Sentiment towards Fundamentals (3.6), Option Sentiment (1.5), Stock Price Trend (0.2), and Price Level Sentiment (0) will drive up the price. The forces of Sector Price Trend (-0.2), Valuation Sentiment (-1), and Market Risk Appetite (-4.6) will drive down the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| NVS | ||||||||||||||
| Date | Attention | Price | StdDev | Price Level | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-16 | 0%(0%) | 130.77 | 2.91% | 68 | 0.62% | 0% | 0.2 | 0 | 1% | -0.1 | Long | 55% | 3.6 | 7 |
| 2025-10-15 | 0%(0%) | 129.97 | 3.04% | 64 | -0.22% | -0.15% | -0.3 | 0 | 1% | 0.5 | Long | 55% | 5.7 | -1 |
| 2025-10-14 | 0%(0%) | 130.26 | 3.12% | 68 | 0.88% | 0.15% | 0.2 | 0 | 1% | 2.1 | Long | 55% | 5.1 | -1 |
| 2025-10-13 | 0%(0%) | 129.12 | 3.2% | 63 | -0.7% | 0.38% | 0.1 | 0 | 1% | 2.1 | Long | 55% | 5.1 | -1 |
| 2025-10-12 | 0%(0%) | 0.3 | 0 | 1.7 | 5.1 | -1 | ||||||||
| 2025-10-11 | 0%(0%) | 0.3 | 0 | 1.7 | 5.1 | -1 | ||||||||
| 2025-10-10 | 0%(0%) | 130.03 | 3.21% | 70 | -0.79% | 0.54% | 0.3 | 0 | 1% | 2 | Long | 55% | 5.1 | -1 |
| 2025-10-09 | 0%(0%) | 131.06 | 3.15% | 78 | -0.94% | 0.7% | 0.9 | 0 | 1% | 2.2 | Long | 55% | 4.2 | -1 |
| 2025-10-08 | 0%(0%) | 132.31 | 3.03% | 88 | 0.58% | 0.7% | 1 | 0 | 1% | 2.1 | Long | 55% | 3.9 | -1 |
| 2025-10-07 | 0%(0%) | 131.55 | 2.86% | 88 | -0.53% | 0.71% | 1.4 | 0 | 1% | 1.2 | Long | 55% | 3.8 | -1 |
| Long is the preferred trading strategy with 55% chance of being right. Improving trend sentiment and positive hourly trend. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||
| 2026-02-14 14:31:01 The promising outcomes of Fabhalta trials suggest a favorable outlook towards receiving FDA approval, which could significantly benefit Novartis. |
| 2026-02-14 14:31:01 The thin late-stage pipeline of Novartis raises concerns about the company’s ability to maintain growth through the upcoming years. |
| 2026-02-14 14:31:01 Despite the impact of generics, Novartis plans for mid-single-digit revenue growth driven by the performance of other key products. |
| 2026-02-14 14:31:01 Positive results from late-stage trials for Fabhalta indicate a strong potential for drug approval and effective treatment for rare kidney disease. |
| 2026-02-14 14:31:01 The introduction of Entresto generics could negatively impact Novartis' revenue, which is estimated to be around 9%. |